Its a little frustrating something like this can happen and we now have to wait for the quarterly to get some insight (if were lucky). I do agree Akki in that maybe he wasnt suited to the ceo role and frustration finally got the better of him.
I guess the big questions now is who has been driving the scientific development over the past year or two and have they actually made any further advances with myc or anything else. I guess if he hasnt been involved in the science for some time it might not be too much of an issue but at this point it feels like a parent abandoning its child? With everything he has gone through with this company it is hard to believe he can just walk away. I was concerned that if nothing substantial was in the next update regarding progress then we must have hit a major road block. Not sure what to think now.
Given the choice of director buying on market or director walking away i think this is not the better option
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)